Abstract
Joint modelling for mixed longitudinal responses has played a prominent part in disease decision-making. It is based on a joint strategy of estimating joint likelihood with shared random effects. Non-ignorable missingness in outcomes increases complexity in joint model; a shared parameter model is proposed to incorporate non-ignorable missing data for joint modelling of longitudinal responses and missing data mechanism. Parameters are estimated under the Bayesian paradigm and implemented via Markov chain Monte Carlo (MCMC) methods with Gibbs sampler. To demonstrate the effectiveness of the proposed method, the joint model is applied to analyze a prostate cancer dataset. The objective is to assess whether there is an association between two mixed longitudinal biomarkers, which could have important implications for understanding disease progression and guiding treatment decisions. The dataset contains non-monotone missingness pattern. To evaluate the performance and robustness of the proposed joint model, simulation studies are conducted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study is based on a retrospective analysis of secondary analysis of administrative data. Mayo Hospital informed patients that their collected data might be used for research purposes. Therefore, no informed consent to participate is needed as approved by the ethical committee of University of the Punjab. Personal information was kept confidential to others during data collection from reports. The study has been conducted in accordance with the Declaration of Helsinki. The study was approved by the College of Statistical and Actuarial Sciences Research Board and the ethical committee at the University of the Punjab, Lahore Pakistan.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
madiha.phd.stat{at}pu.edu.pk
kamal0shahid{at}gmail.com
Data Availability
Data cannot be shared publicly because it is secondary data taken from a hospital. Data is available from the corresponding author upon reasonable request for researchers who meet the criteria for access to confidential data.
